JAN vs DOC Stock Comparison

Janus Living and Healthpeak Properties Prices as of Nov 13, 2026 Peers: Industry group
JAN Janus Living, Inc.
$31.82 +9.8% 1M
Market cap
$7.46B
P/E
–
Revenue (TTM)
$835.56M
Div. yield
1.29%
Healthcare REITs Real Estate

Head to Head

6 decided of 12

Healthpeak Properties leads on 6 of the 12 questions below (Healthpeak Properties 6). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionJANDOCLeader
Larger companyMarket capitalisation $7.46B $13.78B DOC
Cheaper on earningsLower P/E, profitable companies only -3,327x 36.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 318.2x — –
Faster revenue growthRevenue growth, trailing twelve months — +9.4% –
More profitableNet margin, trailing twelve months -0.3% 12.3% DOC
Better return on capitalReturn on invested capital -21.2% -7.1% DOC
Less leveragedLower net debt / EBITDA — -962.8x –
Higher dividend yieldTrailing dividend yield 1.29% 6.54% DOC
Better 1-year returnPrice return, last 12 months — +14.2% –
Better 5-year returnAnnualised price return, 5 years — -10.0%/yr –
Less volatileAnnualised volatility, 1 year 28.9% 28.6% DOC
Higher overall scoreMean of the five percentile scores vs peers 25/100 46/100 DOC

Percentile Scorecard

JANDOC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisJANDOC
Valuation 1 #147 of 149 34 #99 of 149
Growth – 45 #82 of 147
Profitability 26 #107 of 144 43 #83 of 144
Financial Health 72 #43 of 149 58 #63 of 149
Shareholder Returns 2 #136 of 139 50 #70 of 139
Overall 25 46
  • JAN ranked among 150 companies in Property REITs
  • DOC ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodJANDOCSPY
1 month +9.8%+6.7% -2.0%
3 months +3.9%-3.8% -2.8%
6 months +19.3%+3.3% +2.0%
Year to date —+24.3% +10.6%
1 year —+14.2% +12.2%
3 years —+18.0% +68.1%
3 years, per year —+5.7% +18.9%
5 years —-40.9% +61.4%
5 years, per year —-10.0% +10.1%
10 years —-28.9% +248.5%
10 years, per year —-3.3% +13.3%

Risk

MeasureJANDOCSPY
Volatility, 1Y 28.9%28.6% 13.6%
Downside volatility, 1Y 26.9%24.1% 13.9%
Beta vs S&P 500, 1Y -0.010.34 1.00
Return / volatility, 1Y —0.49 0.90
Max drawdown, 5Y -13.8%-57.6% -25.4%
From 52-week high -3.2%-12.4% -3.2%
52-week high $32.88$22.83 $779.14
52-week low $22.88$15.78 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleJANDOC
P/E now vs peer median -3,327xmedian 26.1x 36.5xmedian 26.1x
P/S now vs peer median 8.9xmedian 4.3x 4.5xmedian 4.3x
EV/EBITDA now vs peer median -10.9xmedian 14.5x -3,321xmedian 14.5x
P/FCF now vs peer median -3.5xmedian 21.4x -6.0xmedian 21.4x
P/B now vs peer median 1.8xmedian 1.2x 1.3xmedian 1.2x
PEG now vs peer median —median 1.75 4.77median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsJANDOC
Revenue $835.56M $3.06B
Gross profit – $1.74B
Operating income -$871.49M -$1.20B
Net income $38.54M $443.23M
Free cash flow -$2.15B -$2.30B
EPS (diluted) $-0.01 $0.55
Cash & equivalents $338.06M $514.31M
Total debt – $6.14B
Shares (diluted) 225.97M 689.51M
Enterprise value $5.61B $12.92B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricJANDOC
P/E -3,327x 36.5x
P/FCF -3.5x -6.0x
P/Operating cash flow 30.0x 10.8x
P/S 8.9x 4.5x
P/B 1.8x 1.3x
P/Tangible book 2.0x 1.4x
EV/EBITDA -10.9x -3,321x
EV/EBIT -8.2x -16.2x
EV/Revenue 8.5x 6.3x
EV/FCF -3.3x -8.4x
EV/Operating cash flow 28.7x 15.3x
PEG (3Y EPS CAGR) – 4.77

Growth

14 metrics
MetricJANDOC
Revenue growth (1Y) – 9.4%
Revenue CAGR (3Y) – 12.5%
Gross profit growth (1Y) – 3.4%
Gross profit CAGR (3Y) – 11.6%
Operating income growth (1Y) – -83.3%
Operating income CAGR (3Y) – -92.0%
Net income growth (1Y) – 2,652%
Net income CAGR (3Y) – 17.9%
EPS growth (1Y) – 1,076%
EPS CAGR (3Y) – 7.7%
Operating cash flow growth (1Y) – 2.3%
Operating cash flow CAGR (3Y) – 10.9%
Free cash flow growth (1Y) – -787.4%
Free cash flow CAGR (3Y) – -326.3%

Profitability

14 metrics
MetricJANDOC
Gross margin – 56.8%
EBITDA margin -78.3% -0.2%
Operating margin -104.3% -39.2%
Pretax margin 4.7% 13.5%
Net margin -0.3% 12.3%
FCF margin -257.6% -75.1%
Operating cash flow margin 29.7% 41.5%
Return on equity 1.0% 4.2%
Return on assets 0.8% 1.9%
Return on invested capital -21.2% -7.1%
Return on capital employed – –
Asset turnover 0.2x 0.1x
Cash conversion (OCF / net income) 6.4x 2.9x
Stock comp / revenue 0.1% 0.6%

Financial Health

11 metrics
MetricJANDOC
Debt / assets – 27.4%
Debt / equity – 0.6x
Net debt / EBITDA – -962.8x
Debt / FCF – -2.7x
Liabilities / assets 21.0% 51.9%
Equity / assets 79.0% 48.1%
Interest coverage -407.8x -14.7x
Current ratio – –
Quick ratio – –
Cash ratio – –
Altman Z-score – –

Shareholder Returns

7 metrics
MetricJANDOC
Dividend yield 1.3% 6.5%
Net buyback yield -11.2% 0.7%
Shareholder yield -9.9% 7.3%
Payout ratio (earnings) – 190.5%
Payout ratio (FCF) – -36.7%
Dividend growth (1Y) – 0.3%
Dividend CAGR (3Y) – -8.9%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusJANDOC
Forward P/E 318.2xFY2026 –
EPS, next fiscal year $0.10FY2026 –
EPS growth, next FY +150.0%FY2026 –
EPS growth, the year after -10.0% –
Revenue, next fiscal year $885.94MFY2026 $2.86BFY2026
Revenue growth, next FY +27.8%FY2026 +3.7%FY2026
Revenue growth, the year after +42.3% +12.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersJANDOC
Held by institutions 38.1% 95.7%
Institutions holding 162 761
Change in shares held, QoQ +56.8% -2.9%
Institutions buying 137 341
Institutions selling 19 314
Buyers to sellers 7.21 1.09

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

JANDOC
JAN 1.00 0.35
DOC 0.35 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, JAN and DOC?

Healthpeak Properties (DOC) is the largest by market capitalisation: Janus Living (JAN) $7.46B, Healthpeak Properties (DOC) $13.78B.

Which company is more profitable?

Healthpeak Properties (DOC) has the highest net margin (Janus Living (JAN) -0.3%, Healthpeak Properties (DOC) 12.3%). On return on invested capital, Healthpeak Properties (DOC) leads (Janus Living (JAN) -21.2%, Healthpeak Properties (DOC) -7.1%).

Which pays a higher dividend?

Healthpeak Properties (DOC) has the highest dividend yield: Janus Living (JAN) 1.29%, Healthpeak Properties (DOC) 6.54%.

Which stock is riskier?

By one-year price volatility, Healthpeak Properties (DOC) has been the steadiest (Janus Living (JAN) 28.9%, Healthpeak Properties (DOC) 28.6%). Volatility measures how widely the price swings, not the risk of the business.

Do JAN and DOC move together?

Their daily returns over the past year have a correlation of 0.35, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, JAN and DOC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Healthpeak Properties (DOC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.